Jacob deGrom

DeGrom's first season with the Rangers after inking a five-year, $185 million contract ended after just six starts when he required Tommy John surgery in mid-June. Unsurprisingly, he was brilliant when on the mound, boasting an absurd 45:4 K:BB over 30.1 innings while averaging 98.7 mph with his fastball. The hope is that the two-time Cy Young winner can rejoin the Rangers' rotation at some point after the All-Star break, but given that it was his second UCL repair and the fact that he has made just 44 starts over the last four seasons, the rehab could take a little longer than your normal Tommy John surgery. He's been indisputably the best pitcher in the game when healthy, but unless you have unlimited IL spots it's difficult to advocate taking deGrom in a redraft in 2024.

Coming off a season where deGrom made only 15 starts while dealing with elbow issues, it took only one spring start before he experienced shoulder soreness. It was soon diagnosed as a stress reaction in his right scapula, which sidelined him until August 2, though that latest injury didn't stop the Rangers from doling out a $185 million contract. The oft-injured right-hander gathered 64.1 inning over 11 starts in 2022, with typically dominant results. He was able to throw all his pitches, again relying on a 99-mph fastball about half of the time. There isn't a bigger wild card in fantasy drafts than deGrom. The pinnacle is the top pitcher in the game, and if he pitches anywhere close to his usual level, deGrom only needs around 150 frames to achieve No. 1 status. He's going to be drafted as one of the first 10 starters off the board, and if he has good spring, it could be top three. Just keep in mind, he'll be 35 years old and including rehab, deGrom has only thrown 182 innings over the last two seasons

It's a shame we'll never know what would have happened if deGrom didn't deal with multiple injuries. Unfortunately, right lat inflammation, right flexor tendinitis, shoulder soreness and a partial UCL tear had other plans. In his 92 frames, deGrom recorded a 45.1 K% and 3.4 BB%, resulting in a 41.7 K-BB% mark which would have been the best in history for a qualified starting pitcher. Even though his ERA estimators were still well below 2.00, it's hard to imagine deGrom would have finished the year with a 1.08 mark. It is encouraging he could have returned down the stretch if the Mets were in playoff contention, but deGrom still turns 34 years old in June and he's coming off an injury-riddled campaign. The scary part is deGrom needs only 120 innings to be a top-10 starter. This one isn't about next-level analytics; it's a matter of confidence in his health and risk tolerance.

DeGrom nearly pulled off the Cy Young three-peat, posting a sub-2.50 ERA for the third straight year and once again finishing as a finalist in the National League. He ultimately placed third in the voting, but he would have been a worthy winner, with the only real knock being one-and-a-half missed starts due to neck and hamstring issues. The right-hander dialed his fastball up a tick to 98.6 mph on average and saw a corresponding increase in strikeout rate to a career-high 38.8%. His previous high was 32.2% set in 2018. It's worth noting that his opponents' barrel rate and average exit velocity jumped to 9.6% and 88.2 mph, respectively, up from 5.0% and 86.5 mph in 2019. Further, the velocity spike could be seen as slightly worrying given they are sometimes a precursor to injury. These are relatively minor factors to consider when splitting hairs in the first round of 2021 fantasy drafts.

For the second straight season, deGrom won the National League Cy Young Award. Remarkably, he's won just 21 games over that span, but his pristine ratios have properly swayed the voters to do the right thing. Like all great pitchers, deGrom constantly adapts. His fastball velocity ticked up for the fourth consecutive campaign, so deGrom threw it a little more. He also increased slider usage while cutting back on his curve and bagging the sinker. The result was a 26.2 K-BB%, fourth best in the league. The main difference between 2019 and the previous season was deGrom's home-run rate doubled, accounting for the bump in ERA to 2.43 after a 1.70 mark in 2018. With Max Scherzer's health a concern, deGrom is a candidate to be the first pitcher off the board, along with Gerrit Cole and Justin Verlander. If wins weren't still an issue, deGrom would likely be the consensus top pick among hurlers.

If deGrom had not won the NL Cy Young Award, it would have been a damn shame. DeGrom shoved all season and pitched with a laughable amount of run support. His average pitch velocities went up across the board, and combined with precision command, explain how he was able to dominate hitters in nearly every single outing of 2018. DeGrom had 21 starts in which he allowed one or zero runs and he had nine wins to show for his efforts in those outings. He had just one game in which he allowed more than three runs. He should have won 25, but won 10. He has strikeouts and ratios in spades, and the Mets' additions to the lineup and the bullpen should lead to more wins in 2019.

After undergoing ulnar nerve surgery at the end of the 2016 season, deGrom regained his velocity and stepped up as the Mets' best starter last season. For the first time in his career, he eclipsed 200 innings, and parlayed the increased workload and an improved strikeout rate (10.7 K/9) into a career-high 239 punchouts. Little changed with his pitch mix, although deGrom used his slider at a 22.7 percent rate, the most he's thrown that offering to this point in his career, and the adjustment came at the expense of fewer fastballs. He was more willing than ever to challenge hitters within the strike zone (51.5 percent), and despite that, hitters made contact on those pitches at a career-low 73.5 percent rate against him. If the improved walk rate he carried in the second half (2.1 BB/9) is maintained over a full season with the increase in strikeouts, deGrom has the tools necessary to contend for the Cy Young Award in 2018.

New York's super rotation held together for all of a year as two of the three aces suffered through injuries that eventually required surgery. DeGrom's season was markedly better than Matt Harvey's, but he imploded late and missed the final month of the season thanks to ulnar nerve surgery. Through 21 starts, he had a 2.30 ERA and 1.05 WHIP with 129 strikeouts, all of which is peak deGrom. The surgery was a clean-up around the nerve while the nerve itself was healthy and in good shape. This all bodes well for a strong recovery and winter reports suggest deGrom won't be limited in spring training. Don't be surprised if deGrom's price rises throughout spring as he proves himself healthy during the Grapefruit League and earns back the confidence of drafters. He was a 6th-7th round bargain in some winter drafts, but could wind up back in the 4th-5th round area where more frontliners are going for 2017. With health, buy in bulk.

While deGrom's season ended on a disappointing note — he gave up four runs in the fifth inning of a Game 2 loss to the Royals in the World Series — it did not detract from what was an absolutely stellar campaign for the 27-year-old. DeGrom improved upon his already excellent strikeout and walk rates, with his 22.2% K-BB% ranking seventh among all qualified starters in Major League Baseball, ahead of Jake Arrieta, Chris Archer, David Price, and teammate Matt Harvey. He gained a couple ticks on each of his four offerings, with his fastball consistently reaching the mid-90s, and was able to get more swings at pitches outside of the strike zone. The Mets took measures late in the year to limit his workload, and he acknowledged in the postseason that he was fatigued, but deGrom is now five years removed from Tommy John surgery and should be unrestricted in 2016.

This is why the prospecting game is so difficult. DeGrom was never seen as much of a prospect, especially if the list in question stopped at 10 names. His excellent 2014 shocked everyone. He never had that carrying tool or standout plus pitch, but instead was just kind of solid across-the-board. He is the embodiment of the Bill James adage that is usually applied to a team construct: if you grade average everywhere, the package winds up being very good. He has four reliable pitches (all thrown at least 10% of the time) with the fastball leading the way (61%), a slider he features against righties, a changeup that he uses against lefties and a curveball that he throws at hitters on both sides of the plate. This isn't some soft-tossing non-prospect who caught lightning in a bottle, though. He has a strong 93-95 mph fastball that yielded the third-lowest OPS-against in the league (.585) and third-highest strikeout rate (27.4%). The fact that he doesn’t overly rely on any of his four pitches for his 26.0% strikeout rate bodes well for it holding firm. Don’t pay for a repeat, especially if the hardware he won drives the price up, but he should be a very useful asset again in 2015.

DeGrom began the year at High-A St. Lucie, but ascended to Triple-A Las Vegas before the season concluded. He struck out 63 batters over 75.2 innings in Triple-A ball, finishing the season with a 4-2 record for the 51s. DeGrom throws strikes consistently, using a low-90s fastball, average breaking pitch and solid changeup. He underwent Tommy John surgery, missing all of the 2011 season, but has been a fast riser since returning to action. DeGrom was added to the 40-man roster in November to protect him from the Rule 5 draft and he will likely start the year in Las Vegas, but he could see Citi Field during the upcoming season.